|
Tuberculosis Global Clinical Trials Review, H1, 2012
|
|||||||||||
| Preis** (Lieferformat): |
Versandkostenfrei ** WICHTIG: Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs. |
Zahlen und Fakten zur Studie: | 102 seiten | |||||||||
| Inhalt der Studie: |
Introduction
GlobalData's clinical trial report, “Tuberculosis Global Clinical Trials Review, H1, 2012" provides data on the Tuberculosis clinical trial scenario. This report provides elemental infor.....
Introduction GlobalData's clinical trial report, “Tuberculosis Global Clinical Trials Review, H1, 2012" provides data on the Tuberculosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Tuberculosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Tuberculosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Highlights Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies [Studien Infos ausblenden] |
|||||||||||
|
Table of Contents Table of Contents 2 List of Tables 5 List of Figures 6 Introduction 7 Tuberculosis 7 Report Guidance 7 Clinical Trials by Region 8 Clinical Trials by Country 9 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11 Top Five Countries Contributing to Clinical Trials in Europe 12 Top Countries Contributing to Clinical Trials in North America 13 Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14 Top Five Countries Contributing to Clinical Trials in Central and South America 15 Clinical Trials by BRIC Nations 16 Clinical Trials by G7 Nations 17 Clinical Trials in G7 Nations by Trial Status 18 Clinical Trials by E7 Nations 19 Clinical Trials in E7 Nations by Trial Status 20 Clinical Trials by Phase 21 In Progress Trials by Phase 22 Clinical Trials by Trial Status 23 Unaccomplished Trials of Tuberculosis 24 Subjects Recruited Over a Period of Time 27 Prominent Sponsors 28 Top Companies Participating in Tuberculosis Therapeutics Clinical Trials 30 Prominent Drug Comparison 32 Clinical Trial Profiles 33 Clinical Trial Overview of Top Companies 33 GlaxoSmithKline plc 33 Clinical Trial Overview of GlaxoSmithKline plc 33 Pfizer Inc. 34 Clinical Trial Overview of Pfizer Inc. 34 Johnson & Johnson 35 Clinical Trial Overview of Johnson & Johnson 35 Aeras Global Tb Vaccine Foundation 36 Clinical Trial Overview of Aeras Global Tb Vaccine Foundation 36 Global Alliance for TB Drug Development 37 Clinical Trial Overview of Global Alliance for TB Drug Development 37 Otsuka Pharmaceutical Co., Ltd. 38 Clinical Trial Overview of Otsuka Pharmaceutical Co., Ltd. 38 Vakzine Projekt Management GmbH 39 Clinical Trial Overview of Vakzine Projekt Management GmbH 39 AstraZeneca PLC 40 Clinical Trial Overview of AstraZeneca PLC 40 Sanofi 41 Clinical Trial Overview of Sanofi 41 EPICENTRE Biotechnologies 42 Clinical Trial Overview of EPICENTRE Biotechnologies 42 Apothecaries Private Limited 43 Clinical Trial Overview of Apothecaries Private Limited 43 Tibotec BVBA 44 Clinical Trial Overview of Tibotec BVBA 44 G.S.V.M. Medical College 45 Clinical Trial Overview of G.S.V.M. Medical College 45 RIEMSER Arzneimittel AG 46 Clinical Trial Overview of RIEMSER Arzneimittel AG 46 Archivel Farma S.L. 47 Clinical Trial Overview of Archivel Farma S.L. 47 Lupin Limited 48 Clinical Trial Overview of Lupin Limited 48 Acoustic MedSystems, Inc. 49 Clinical Trial Overview of Acoustic MedSystems, Inc. 49 Merz GmbH & Co. KGaA 50 Clinical Trial Overview of Merz GmbH & Co. KGaA 50 Novartis AG 51 Clinical Trial Overview of Novartis AG 51 Sequella, Inc. 52 Clinical Trial Overview of Sequella, Inc. 52 Clinical Trial Overview of Top Universities / Institutes / Hospitals 53 The National Institute of Allergy and Infectious Diseases 53 Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 53 University of Oxford 56 Clinical Trial Overview of University of Oxford 56 Centers for Disease Control and Prevention 58 Clinical Trial Overview of Centers for Disease Control and Prevention 58 University of Cape Town 60 Clinical Trial Overview of University of Cape Town 60 Statens Serum Institut 61 Clinical Trial Overview of Statens Serum Institut 61 Johns Hopkins University 62 Clinical Trial Overview of Johns Hopkins University 62 French National Agency for Research on AIDS and Viral Hepatitis 63 Clinical Trial Overview of French National Agency for Research on AIDS and Viral Hepatitis 63 National Taiwan University Hospital 64 Clinical Trial Overview of National Taiwan University Hospital 64 Seoul National University Hospital 65 Clinical Trial Overview of Seoul National University Hospital 65 Tuberculosis Research Centre 66 Clinical Trial Overview of Tuberculosis Research Centre 66 Assistance Publique - Hopitaux de Paris 67 Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 67 All India Institute of Medical Sciences 68 Clinical Trial Overview of All India Institute of Medical Sciences 68 Yonsei University 69 Clinical Trial Overview of Yonsei University 69 Ministry of Science & Technology 70 Clinical Trial Overview of Ministry of Science & Technology 70 Taipei Medical University WanFang Hospital 71 Clinical Trial Overview of Taipei Medical University WanFang Hospital 71 Hopitaux Universitaires de Geneve 72 Clinical Trial Overview of Hopitaux Universitaires de Geneve 72 Health Protection Agency 73 Clinical Trial Overview of Health Protection Agency 73 Radboud University 74 Clinical Trial Overview of Radboud University 74 Texas Tech University Health Sciences Center 75 Clinical Trial Overview of Texas Tech University Health Sciences Center 75 Harvard School of Public Health 76 Clinical Trial Overview of Harvard School of Public Health 76 Five Key Clinical Profiles 77 Appendix 98 Abbreviations 98 Definitions 98 Research Methodology 100 Secondary Research 100 About GlobalData 101 Contact Us 101 Disclaimer 101 Source 102 [Inhaltsverzeichnis ausblenden] |
||||||||||||
|
List of Tables Tuberculosis Therapeutics Market, Global, Clinical Trials by Zone, 2012* 8 Tuberculosis Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9 Tuberculosis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10 Tuberculosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 11 Tuberculosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 12 Tuberculosis Therapeutics Clinical Trials, North America, Top Countries, 2012* 13 Tuberculosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012* 14 Tuberculosis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012* 15 Tuberculosis Therapeutics Clinical Trials, BRIC Countries, 2012* 16 Tuberculosis Therapeutics Clinical Trials, G7 Countries, 2012* 17 Tuberculosis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18 Tuberculosis Therapeutics Clinical Trials, E7 Countries, 2012* 19 Tuberculosis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20 Tuberculosis Therapeutics Market, Global, Clinical Trials by Phase, 2012* 21 Tuberculosis Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 22 Tuberculosis Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23 Tuberculosis Therapeutics Market, Global, Suspended Clinical Trials, 2012* 24 Tuberculosis Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 25 Tuberculosis Therapeutics Market, Global, Terminated Clinical Trials, 2012* 26 Tuberculosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 27 Tuberculosis Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 29 Tuberculosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 31 Tuberculosis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 32 Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012* 33 Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 34 Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2012* 35 Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Aeras Global Tb Vaccine Foundation, 2012* 36 Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Global Alliance for TB Drug Development, 2012* 37 Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Pharmaceutical Co., Ltd., 2012* 38 Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Vakzine Projekt Management GmbH, 2012* 39 Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012* 40 Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012* 41 Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by EPICENTRE Biotechnologies, 2012* 42 Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Apothecaries Private Limited, 2012* 43 Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tibotec BVBA, 2012* 44 Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by G.S.V.M. Medical College, 2012* 45 Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by RIEMSER Arzneimittel AG, 2012* 46 Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Archivel Farma S.L., 2012* 47 Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Lupin Limited, 2012* 48 Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Acoustic MedSystems, Inc., 2012* 49 Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merz GmbH & Co. KGaA, 2012* 50 Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 51 Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sequella, Inc., 2012* 52 Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2012* 53 Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2012* 56 Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Centers for Disease Control and Prevention, 2012* 58 Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cape Town, 2012* 60 Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Statens Serum Institut, 2012* 61 Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2012* 62 Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by French National Agency for Research on AIDS and Viral Hepatitis, 2012* 63 Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2012* 64 Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2012* 65 Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tuberculosis Research Centre, 2012* 66 Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2012* 67 Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2012* 68 Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Yonsei University, 2012* 69 Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ministry of Science & Technology, 2012* 70 Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Taipei Medical University WanFang Hospital, 2012* 71 Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hopitaux Universitaires de Geneve, 2012* 72 Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Health Protection Agency, 2012* 73 Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2012* 74 Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Texas Tech University Health Sciences Center, 2012* 75 Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Harvard School of Public Health, 2012* 76 List of Figures Tuberculosis Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 8 Tuberculosis Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9 Tuberculosis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10 Tuberculosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 11 Tuberculosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 12 Tuberculosis Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 13 Tuberculosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012* 14 Tuberculosis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012* 15 Tuberculosis Therapeutics Clinical Trials, BRIC Countries (%), 2012* 16 Tuberculosis Therapeutics Clinical Trials, G7 Countries (%), 2012* 17 Tuberculosis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18 Tuberculosis Therapeutics Clinical Trials, E7 Countries (%), 2012* 19 Tuberculosis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20 Tuberculosis Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 21 Tuberculosis Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 22 Tuberculosis Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23 Tuberculosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 27 Tuberculosis Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 28 Tuberculosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 30 Tuberculosis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 32 GlobalData Methodology 100 [Tabellenverzeichnis ausblenden] |
||||||||||||
| Hinweis: | * Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs | |||||||||||
|
|
||||||||||||
